| Sign In to gain access to subscriptions and/or personal tools. |
Lamotrigine treatment of aggression in female borderline patients, Part II: an 18-month follow-up
1 Clinic for Psychosomatic Medicine and Psychotherapy, Medical University
of Graz, Bad Aussee, Austria and University Clinic for Psychiatry 1, PMU,
Salzburg, Austria.
* To whom correspondence should be addressed.
Borderline patients often display pathological aggression. We previously tested lamotrigine, an anti-convulsant, in therapy for aggression in women with borderline personality disorder (BPD) (J Psychopharmacol 2005; 19: 287291), and found significant changes on most scales of the State-Trait Anger Expression Inventory (STAXI) after eight weeks. To assess the longer-term efficacy of lamotrigine in therapy for aggression in women with BPD, this 18-month follow-up observation was carried out, in which patients (treated with lamotrigine: n 5 18; former placebo group: n 5 9) were tested every six months. According to the intent-to-treat principle, significant changes on all scales of the STAXI were observed in the lamotrigine-treated subjects. All subjects tolerated lamotrigine relatively well. Lamotrigine appears to be an effective and relatively safe agent in the longer-term treatment of aggression in women with BPD. Key Words: borderline personality disorder, aggression, lamotrigine
First published on February 28, 2008, doi:10.1177/0269881107084004 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||